Brigitte Widemann, MD

National Cancer Institute
Bethesda, Maryland, United States

Disclosure information not submitted.

Presentation(s):

• Paper 37 - TRABECTEDIN ADMINISTERED AS A 1-HOUR INFUSION IN COMBINATION WITH LOW DOSE IRINOTECAN IN PATIENTS WITH EWING SARCOMA: ANTI-TUMOR ACTIVITY AND REVERSAL OF THE EWS-FLI1 TRANSCRIPTOME

  Friday, November 3, 2023
  10:00 AM – 11:00 AM